Wendell David Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $24.2M | Buy |
96,228
+735
| +0.8% | +$158K | 2.56% | 10 |
|
|
2026
Q1 | $20.8M | Sell |
95,493
-828
| -0.9% | -$184K | 2.26% | 13 |
|
|
2025
Q4 | $22M | Sell |
96,321
-3,431
| -3% | -$782K | 2.24% | 13 |
|
|
2025
Q3 | $23.1M | Sell |
99,752
-11
| -0% | -$2.24K | 2.28% | 12 |
|
|
2025
Q2 | $18.5M | Sell |
99,763
-2,106
| -2% | -$391K | 1.86% | 15 |
|
|
2025
Q1 | $21.3M | Sell |
101,869
-305
| -0.3% | -$59.3K | 2.13% | 13 |
|
|
2024
Q4 | $18.2M | Sell |
102,174
-1,827
| -2% | -$336K | 1.8% | 15 |
|
|
2024
Q3 | $20.5M | Sell |
104,001
-500
| -0.5% | -$93.3K | 1.96% | 15 |
|
|
2024
Q2 | $17.9M | Buy |
104,501
+112
| +0.1% | +$18.6K | 1.83% | 16 |
|
|
2024
Q1 | $19M | Buy |
104,389
+89
| +0.1% | +$15.3K | 1.92% | 13 |
|
|
2023
Q4 | $16.2M | Buy |
104,300
+1,025
| +1% | +$149K | 1.74% | 17 |
|
|
2023
Q3 | $15.4M | Buy |
103,275
+3,481
| +3% | +$511K | 1.81% | 17 |
|
|
2023
Q2 | $13.4M | Sell |
99,794
-868
| -0.9% | -$127K | 1.52% | 22 |
|
|
2023
Q1 | $16M | Sell |
100,662
-913
| -0.9% | -$140K | 1.9% | 16 |
|
|
2022
Q4 | $16.4M | Sell |
101,575
-180
| -0.2% | -$27.6K | 2.02% | 16 |
|
|
2022
Q3 | $13.7M | Sell |
101,755
-644
| -0.6% | -$92.4K | 1.84% | 18 |
|
|
2022
Q2 | $15.7M | Buy |
102,399
+325
| +0.3% | +$49.7K | 1.99% | 16 |
|
|
2022
Q1 | $16.5M | Sell |
102,074
-3,113
| -3% | -$452K | 1.84% | 19 |
|
|
2021
Q4 | $14.2M | Sell |
105,187
-1,226
| -1% | -$145K | 1.44% | 25 |
|
|
2021
Q3 | $11.5M | Buy |
106,413
+1,713
| +2% | +$196K | 1.28% | 25 |
|
|
2021
Q2 | $11.8M | Buy |
104,700
+5,412
| +5% | +$610K | 1.32% | 24 |
|
|
2021
Q1 | $10.7M | Buy |
99,288
+410
| +0.4% | +$43.9K | 1.29% | 24 |
|
|
2020
Q4 | $10.6M | Sell |
98,878
-4,728
| -5% | -$454K | 1.3% | 25 |
|
|
2020
Q3 | $9.07M | Sell |
103,606
-884
| -0.8% | -$83.2K | 1.21% | 27 |
|
|
2020
Q2 | $10.3M | Sell |
104,490
-228
| -0.2% | -$20.1K | 1.49% | 22 |
|
|
2020
Q1 | $7.98M | Sell |
104,718
-70
| -0.1% | -$5.96K | 1.35% | 24 |
|
|
2019
Q4 | $9.28M | Sell |
104,788
-600
| -0.6% | -$49.8K | 1.28% | 25 |
|
|
2019
Q3 | $7.98M | Sell |
105,388
-2,730
| -3% | -$187K | 1.17% | 29 |
|
|
2019
Q2 | $7.86M | Sell |
108,118
-2,565
| -2% | -$202K | 1.18% | 28 |
|
|
2019
Q1 | $8.92M | Sell |
110,683
-3,228
| -3% | -$264K | 1.39% | 23 |
|
|
2018
Q4 | $10.5M | Sell |
113,911
-2,269
| -2% | -$200K | 1.89% | 15 |
|
|
2018
Q3 | $11M | Hold |
116,180
| – | – | 1.71% | 16 |
|
|
2018
Q2 | $10.8M | Buy |
116,180
+3,775
| +3% | +$369K | 1.84% | 16 |
|
|
2018
Q1 | $10.6M | Sell |
112,405
-623
| -0.6% | -$68.4K | 1.92% | 16 |
|
|
2017
Q4 | $10.9M | Sell |
113,028
-7,065
| -6% | -$666K | 1.87% | 17 |
|
|
2017
Q3 | $10.7M | Buy |
120,093
+183
| +0.2% | +$13.9K | 1.89% | 18 |
|
|
2017
Q2 | $8.7M | Sell |
119,910
-9,157
| -7% | -$616K | 1.64% | 21 |
|
|
2017
Q1 | $8.41M | Sell |
129,067
-870
| -0.7% | -$54.7K | 1.61% | 21 |
|
|
2016
Q4 | $8.14M | Sell |
129,937
-6,866
| -5% | -$419K | 1.61% | 21 |
|
|
2016
Q3 | $8.63M | Sell |
136,803
-1,360
| -1% | -$88K | 1.7% | 20 |
|
|
2016
Q2 | $8.57M | Sell |
138,163
-9,034
| -6% | -$550K | 1.68% | 20 |
|
|
2016
Q1 | $8.39M | Sell |
147,197
-1,645
| -1% | -$91.7K | 1.63% | 21 |
|
|
2015
Q4 | $8.78M | Sell |
148,842
-257
| -0.2% | -$14.8K | 1.73% | 19 |
|
|
2015
Q3 | $8.05M | Sell |
149,099
-1,475
| -1% | -$96K | 1.65% | 20 |
|
|
2015
Q2 | $10.1M | Sell |
150,574
-550
| -0.4% | -$35.9K | 1.96% | 18 |
|
|
2015
Q1 | $8.92M | Sell |
151,124
-2,850
| -2% | -$172K | 1.71% | 21 |
|
|
2014
Q4 | $10M | Sell |
153,974
-260
| -0.2% | -$16.4K | 1.95% | 19 |
|
|
2014
Q3 | $8.95M | Sell |
154,234
-14,590
| -9% | -$810K | 1.86% | 19 |
|
|
2014
Q2 | $9.45M | Sell |
168,824
-4,499
| -3% | -$236K | 1.99% | 15 |
|
|
2014
Q1 | $8.84M | Sell |
173,323
-1,076
| -0.6% | -$54.4K | 1.92% | 19 |
|
|
2013
Q4 | $9.24M | Sell |
174,399
-6,050
| -3% | -$297K | 2.03% | 14 |
|
|
2013
Q3 | $8.12M | Sell |
180,449
-16,473
| -8% | -$730K | 1.95% | 17 |
|
|
2013
Q2 | $8.07M | Buy |
+196,922
| New | +$8.61M | 2.02% | 17 |
|
Other funds holding ABBV
ATO
Wendell David Associates's ABBV Position: Q2 2026 in Review
Wendell David Associates increased its AbbVie (ABBV) stake by 0.77% in Q2 2026, buying an estimated $158K and bringing the position to 96,228 shares worth $24.2M. The position accounts for 2.56% of the portfolio, ranked #10.
Wendell David Associates first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,742 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Wendell David Associates held 96,228 shares of AbbVie worth $24.2M as of Q2 2026.
- Wendell David Associates bought 735 AbbVie shares in Q2 2026, an estimated $158K.
- AbbVie made up 2.56% of Wendell David Associates's portfolio in Q2 2026, its #10 holding.
- Wendell David Associates first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 1,742 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.